A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits.
Kuschner RA, Russell KL, Abuja M, Bauer KM, Faix DJ, Hait H, Henrick J, Jacobs M, Liss A, Lynch JA, Liu Q, Lyons AG, Malik M, Moon JE, Stubbs J, Sun W, Tang D, Towle AC, Walsh DS, Wilkerson D; Adenovirus Vaccine Efficacy Trial Consortium.
Kuschner RA, et al. Among authors: towle ac.
Vaccine. 2013 Jun 19;31(28):2963-71. doi: 10.1016/j.vaccine.2013.04.035. Epub 2013 Apr 25.
Vaccine. 2013.
PMID: 23623865
Clinical Trial.